Skip to main content
Clinical Trials/JPRN-UMIN000005995
JPRN-UMIN000005995
Completed
未知

Prospective study of efficacy and safety of transcatheter arterial chemoembolization (TACE) with miriplatin for hepatocellular carcinoma. - Prospective study of TACE with miriplatin for hepatocellular carcinoma.

Kyoto Prefectural University of Medicine0 sites200 target enrollmentJuly 19, 2011

Overview

Phase
未知
Intervention
Not specified
Conditions
Hepatocellular carcinoma
Sponsor
Kyoto Prefectural University of Medicine
Enrollment
200
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 19, 2011
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) Refractory pleural effusion or ascites 2\) Encephalopathy 3\) Concurrent disease a) Serious hypertension b) Severe heart disease c) Acute myocardial infarction within 6 months prior to inclusion d) Active double cancer e) Severe mental disorder f) Allergic reaction to iodine contrast material g) Severe drug allergy 4\) Intrahepatic or portal\-caval shunts 5\) Tumor thrombosis in main portal vein or vena cava 6\) Pregnant and lactating females; females of childbearing age unless using effective contraception 7\) Patients who are concluded to be inappropriate to participate in this study by their physicians

Outcomes

Primary Outcomes

Not specified

Similar Trials